Related references
Note: Only part of the references are listed.Recurrence of Gastric Cancer in the Jejunum Close to the Anastomotic Site after Total Gastrectomy
Hiroshi Shintani et al.
CASE REPORTS IN ONCOLOGY (2021)
Acacetin Ameliorates Experimental Colitis in Mice via Inhibiting Macrophage Inflammatory Response and Regulating the Composition of Gut Microbiota
Junyu Ren et al.
FRONTIERS IN PHYSIOLOGY (2021)
Entropy-driven binding of gut bacterial β-glucuronidase inhibitors ameliorates irinotecan-induced toxicity
Hsien-Ya Lin et al.
COMMUNICATIONS BIOLOGY (2021)
Mechanisms of Gegen Qinlian Pill to ameliorate irinotecan-induced diarrhea investigated by the combination of serum pharmacochemistry and network pharmacology
Yihan Wu et al.
JOURNAL OF ETHNOPHARMACOLOGY (2021)
Metastatic small bowel adenocarcinoma: role of metastasectomy and systemic chemotherapy
D. Bhamidipati et al.
ESMO OPEN (2021)
Intestinal barrier dysfunction in irritable bowel syndrome: a systematic review
Nikita Hanning et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2021)
Luteolin prevents irinotecan-induced intestinal mucositis in mice through antioxidant and anti-inflammatory properties
Thaise Boeing et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
Oxyberberine, a novel gut microbiota-mediated metabolite of berberine, possesses superior anti-colitis effect: Impact on intestinal epithelial barrier, gut microbiota profile and TLR4-MyD88-NF-κB pathway
Cailan Li et al.
PHARMACOLOGICAL RESEARCH (2020)
Targeted inhibition of gut bacterial β-glucuronidase activity enhances anticancer drug efficacy
Aadra P. Bhatt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Ancient Chinese Medicine Herbal Formula Huanglian Jiedu Decoction as a Neoadjuvant Treatment of Chemotherapy by Improving Diarrhea and Tumor Response
Yau-Tuen Chan et al.
FRONTIERS IN PHARMACOLOGY (2020)
MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy
Sharon Elad et al.
CANCER (2020)
ABCB1 Genetic Variants as Predictors of Irinotecan-Induced Severe Gastrointestinal Toxicity in Metastatic Colorectal Cancer Patients
Pau Riera et al.
FRONTIERS IN PHARMACOLOGY (2020)
Effect of drug metabolizing enzymes and transporters in Thai colorectal cancer patients treated with irinotecan-based chemotherapy
Chalirmporn Atasilp et al.
SCIENTIFIC REPORTS (2020)
Adjuvant chemotherapy in resected colon cancer: When, how and how long?
Alain J. Gelibter et al.
SURGICAL ONCOLOGY-OXFORD (2019)
Irinotecan: 25 years of cancer treatment
Christian Bailly
PHARMACOLOGICAL RESEARCH (2019)
Synergistic Anti-Tumor Effect of mTOR Inhibitors with Irinotecan on Colon Cancer Cells
Damien Reita et al.
CANCERS (2019)
Traditional Chinese medicine Gegen Qinlian decoction ameliorates irinotecan chemotherapy-induced gut toxicity in mice
Yihan Wu et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
A phase II study of irinotecan combined with S-1 in patients with advanced or recurrent cervical cancer previously treated with platinum based chemotherapy
Seiji Mabuchi et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2019)
Pharmacological inhibition of bacterial β-glucuronidase prevents irinotecan-induced diarrhea without impairing its antitumor efficacy in vivo
Kai-Wen Cheng et al.
PHARMACOLOGICAL RESEARCH (2019)
Flavonoid-rich fraction of Bauhinia forficata Link leaves prevents the intestinal toxic effects of irinotecan chemotherapy in IEC-6 cells and in mice
Camile Cecconi Cechinel-Zanchett et al.
PHYTOTHERAPY RESEARCH (2019)
Coptidis Rhizoma: a comprehensive review of its traditional uses, botany, phytochemistry, pharmacology and toxicology
Jin Wang et al.
PHARMACEUTICAL BIOLOGY (2019)
Nanoliposomal irinotecan with fluorouracil for the treatment of advanced pancreatic cancer, a single institution experience
Danielle C. Glassman et al.
BMC CANCER (2018)
Individualization of Irinotecan Treatment: A Review of Pharmacokinetics, Pharmacodynamics, and Pharmacogenetics
Femke M. de Man et al.
CLINICAL PHARMACOKINETICS (2018)
An Atlas of β-Glucuronidases in the Human Intestinal Microbiome
Rebecca M. Pollet et al.
STRUCTURE (2017)
Real-time imaging of intestinal bacterial β-glucuronidase activity by hydrolysis of a fluorescent probe
Michael Chen et al.
SCIENTIFIC REPORTS (2017)
Systematic review of the diagnostic category muscle dysmorphia
Celso Alves dos Santos Filho et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2016)
Pharmacological effects of berberine and its derivatives: a patent update
Yifeng Jin et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2016)
Irinotecan- and 5-fluorouracil-induced intestinal mucositis: insights into pathogenesis and therapeutic perspectives
Ronaldo A. Ribeiro et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2016)
Protective effect of Bu-Zhong-Yi-Qi decoction, the water extract of Chinese traditional herbal medicine, on 5-fluorouracil-induced intestinal mucositis in mice
H. Gou et al.
HUMAN & EXPERIMENTAL TOXICOLOGY (2016)
Integrative Medicine for Relief of Nausea and Vomiting in the Treatment of Colorectal Cancer Using Oxaliplatin-Based Chemotherapy: A Systematic Review and Meta-Analysis
Meng Hua Chen et al.
PHYTOTHERAPY RESEARCH (2016)
Structure and Inhibition of Microbiome β-Glucuronidases Essential to the Alleviation of Cancer Drug Toxicity
Bret D. Wallace et al.
CHEMISTRY & BIOLOGY (2015)
Protective effects of silymarin on epirubicin-induced mucosal barrier injury of the gastrointestinal tract
Alciona Sasu et al.
DRUG AND CHEMICAL TOXICOLOGY (2015)
Discovery of Specific Inhibitors for IntestinalE. coli β-Glucuronidase throughIn SilicoVirtual Screening
Ta-Chun Cheng et al.
TheScientificWorldJOURNAL (2015)
Herbal Substance, Acteoside, Alleviates Intestinal Mucositis in Mice
Daniel Reinke et al.
GASTROENTEROLOGY RESEARCH AND PRACTICE (2015)
Discovery of Specific Inhibitors for IntestinalE. coli β-Glucuronidase throughIn SilicoVirtual Screening
Ta-Chun Cheng et al.
Scientific World Journal (2015)
Modulation of gut microbiota by berberine and metformin during the treatment of high-fat diet-induced obesity in rats
Xu Zhang et al.
SCIENTIFIC REPORTS (2015)
Mucoadhesive formulation of Bidens pilosa L. (Asteraceae) reduces intestinal injury from 5-fluorouracil-inducedmucositis in mice
Paulo Henrique Marcelino de Avila et al.
TOXICOLOGY REPORTS (2015)
The number of intestinal bacteria is not critical for the enhancement of antitumor activity and reduction of intestinal toxicity of irinotecan by the Chinese herbal medicine PHY906 (KD018)
Wing Lam et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2014)
Old Drug New Use-Amoxapine and Its Metabolites as Potent Bacterial β-Glucuronidase Inhibitors for Alleviating Cancer Drug Toxicity
Ren Kong et al.
CLINICAL CANCER RESEARCH (2014)
Berberine, an Epiphany Against Cancer
Luis Miguel Guaman Ortiz et al.
MOLECULES (2014)
Bacterial beta-glucuronidase inhibition protects mice against enteropathy induced by indomethacin, ketoprofen or diclofenac: mode of action and pharmacokinetics
Kyle S. Saitta et al.
XENOBIOTICA (2014)
Regulation of intestinal epithelial permeability by tight junctions
Takuya Suzuki
CELLULAR AND MOLECULAR LIFE SCIENCES (2013)
Naringenin enhances intestinal barrier function through the expression and cytoskeletal association of tight junction proteins in Caco-2 cells
Sakino Noda et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2013)
Molecular Insights into Microbial β-Glucuronidase Inhibition to Abrogate CPT-11 Toxicity
Adam B. Roberts et al.
MOLECULAR PHARMACOLOGY (2013)
Chemotherapy-induced gut toxicity: are alterations to intestinal tight junctions pivotal?
Hannah R. Wardill et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2012)
Pharmacologic Targeting of Bacterial β-Glucuronidase Alleviates Nonsteroidal Anti-Inflammatory Drug-Induced Enteropathy in Mice
Amanda LoGuidice et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2012)
Alleviating Cancer Drug Toxicity by Inhibiting a Bacterial Enzyme
Bret D. Wallace et al.
SCIENCE (2010)
Toxic effects and their management: daily clinical challenges in the treatment of colorectal cancer
Cathy Eng
NATURE REVIEWS CLINICAL ONCOLOGY (2009)
Severe chemotherapy-induced diarrhea in patients with colorectal cancer: a cost of illness analysis
G Dranitsaris et al.
SUPPORTIVE CARE IN CANCER (2005)
Optimization of parameters for semiempirical methods IV: extension of MNDO, AM1, and PM3 to more main group elements
JJP Stewart
JOURNAL OF MOLECULAR MODELING (2004)
New approaches to prevent intestinal toxicity of irinotecan-based regimens
A Alimonti et al.
CANCER TREATMENT REVIEWS (2004)
Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis
EB Rubenstein et al.
CANCER (2004)
Share Paper
